SÃO PAULO, Brazil, May 22, 2025 – Edan Instruments, Inc. (300206. SZ), a leading healthcare company and medical device manufacturer, showcased its ongoing dedication to localized healthcare innovation at Hospitalar 2025, the premier healthcare expo in Latin America. Held at São Paulo Expo from May 20 - 23, 2025, the event drew over 80,000 professionals from over 80 countries.
“Our presence in Latin America reflects a long-term commitment to advancing healthcare where it’s needed most,” said Ray Lun, Director of the Americas market at EDAN. “We came not only to display our latest products but to deepen our local connections and better understand the unique challenges clinicians face across the region. That’s what drives our innovation.”
The laboratory technology sector welcomed two groundbreaking analyzers making their Latin American debut at the event. The compact i500 redefined benchtop efficiency as one of the world's smallest analyzers, requiring zero maintenance while delivering comprehensive 30+ parameter results. Alongside it, the H90S Series 6-Part auto hematology analyzer with RET detection showcased its advanced technology platform, offering high-end parameters for precision hematology testing.
In ultrasound imaging, the Acclarix LX85 stands as EDAN's first cart-based ultrasound system powered by SynSight zone sonography platform. Combining exceptional image clarity with intelligent LinSync solution, this system gives clinicians diagnostic confidence while optimizing workflow efficiency and practice profitability.
For cardiac diagnostics, EDAN introduces two advanced ECG solutions: the soon-to-be-released SE-1202E 12-channel ECG with a high-resolution touchscreen for enhanced clinical workflow, and the compact SE-310 designed for efficient primary care use. Beyond cardiology, EDAN's patient monitoring portfolio—led by the flagship iV Series—provides complete solutions for diverse care environments, attracting strong interest from healthcare providers modernizing their facilities.
In obstetric and gynecological care, the EDAN F15 fetal & maternal monitor is continuously enhanced based on user insights, delivering precise, reliable monitoring for modern practice. Complementing this, the PA4 Pro biofeedback system offers a compact, intuitive solution for pelvic floor rehabilitation, widely endorsed by clinicians for its effectiveness.
As the company approaches its 30th anniversary in 2025, EDAN continues to view Latin America as a strategic pillar for future growth. Hospitalar remains a vital touchpoint in EDAN’s mission to support healthcare professionals with smart, accessible solutions tailored to real-world practice.
To explore EDAN’s innovations in person, visit Booth C58 at São Paulo Expo through May 23. For more information, please visit www.edan.com.
